150000003839 salts Chemical class 0.000 claims abstract description 80.239000011780 sodium chloride Substances 0.000 claims abstract description 85.150000001875 compounds Chemical class 0.000 claims abstract description 290.239000000556 agonist Substances 0.000 title claims description 18.108020001588 κ-opioid receptors Proteins 0.000 title claims description 29.102000037289 κ-opioid receptors Human genes 0.000 title claims description 29.-1 heterocyclic acetamides Chemical class 0.000 title claims description 69.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US201261606632P priority Critical Priority to US61/606,632 priority Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd Priority to PCT/CN2013/000230 priority patent/WO2013131408A1/en Publication of AU2013230425A1 publication Critical patent/AU2013230425A1/en Application granted granted Critical Publication of AU2013230425B2 publication Critical patent/AU2013230425B2/en Status Ceased legal-status Critical Current Anticipated expiration legal-status Critical Links
Original Assignee Dr Reddys Laboratories Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Yonghua Gai Vijay Potluri Pradip Kumar Sasmal Ashok Tehim Chintakunta VAMSEEKRISHNA Hang Zhang Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Ceased Application number AU2013230425A Other versions AU2013230425A1
Google Patents AU2013230425B2 - Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists AU2013230425B2 - Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists